September 14, 2019
Phase 2b Study of Bulevirtide (With Peginterferon Alfa-2a) in Patients With CHD
Read More
January 30, 2019
Study of AT-527 in Healthy and HCV-Infected Subjects
Read More
January 30, 2019
Study of AT-527 in Healthy and HCV-Infected Subjects
Read More
January 30, 2019
First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C
Read More
January 30, 2019
First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C
Read More
January 30, 2019
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir
Read More
January 30, 2019
A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)
Read More
January 30, 2019
First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1
Read More
January 30, 2019
A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C
Read More
January 30, 2019
First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1
Read More
January 30, 2019
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection
Read More
January 30, 2019
A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B
Read More
Load More
X